Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Healthcare Professionals and Consumers

The Irish Medicines Board encourages reporting of any suspected adverse reactions by healthcare professionals and consumers.

Healthcare Professionals in particular are reminded that the IMB wishes to receive the following reports:-

  • All suspected teratogenic effects
  • All suspected reactions to new medicines (i.e. those authorised for less than five years)
  • All suspected reactions to vaccines
  • Serious* suspected reactions to established products
  • Any suspected increase in the frequency of non-serious reactions

Further information on adverse reaction reporting can be found on the Reporting Suspected Product Problems page.

* Definition of Serious:
The term 'serious adverse reaction' means an adverse reaction which results in death, is life-threatening, requires in-patient hospitalisation or prolongation of existing hospitalisation, results in persistent or significant disability, or incapacity, or in a congenital anomaly/birth defect.

Life threatening in this context refers to a reaction in which the patient is at risk of death at the time of the reaction; it does no refer to a reaction that hypothetically might have caused death if more severe.


Date Printed: 17 May 2012

© Irish Medicines Board 2012 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971